Navigation Links
GSK Notice of Third Quarter 2008 Results Announcement and Teleconference
Date:10/20/2008

PHILADELPHIA, Oct. 20 /PRNewswire-FirstCall/ -- On Wednesday, October 22, 2008, GlaxoSmithKline plc (NYSE: GSK) will announce its third quarter financial results for the three months ended September 30, 2008. The announcement is scheduled for release to the London Stock Exchange at approximately 12:00pm UK, 7:00 am EDT.

At 10:00 am EDT, media are invited to attend a global teleconference for analysts and investors, hosted by Andrew Witty, Chief Executive Officer and Julian Heslop, Chief Financial Officer.
To listen to the conference please dial the number below:

US toll free: 866 831 6291

Please quote: GSK Q3 Results

A live audio webcast will begin at the same time as the teleconference, 10:00 am EDT, and can be accessed directly via the GlaxoSmithKline website: http://www.gsk.com.

An archived version of this webcast will be available from the GSK website at approximately 2:00 pm EDT on the same day.


'/>"/>
SOURCE GlaxoSmithKline plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
2. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
3. Neurobiological Technologies, Inc. Reports Receipt of Notice From Nasdaq
4. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
5. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
6. YM BIOSCIENCES NOTICE OF ANNUAL MEETING OF SHAREHOLDERS AND NOMINATION OF DIRECTORS
7. Maxygen Third Quarter 2007 Financial Results Conference Call Notice
8. Notice of Conference Call and Webcast
9. Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
10. Healthcare Technologies, Ltd. Receives Notice From Nasdaq
11. Tapestry Receives Notice Regarding Minimum Bid Price Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017   Boston Biomedical ... cancer therapeutics designed to target cancer stemness pathways, today ... S. Andrews as Chief Executive Officer, effective April ... Chiang J. Li , M.D., FACP, who has ... years ago. Under his leadership, Boston Biomedical has grown ...
(Date:3/22/2017)... Ca (PRWEB) , ... March 21, 2017 , ... ... clearance of biologics. To acquire information on the desired increase and/or decrease in ... biopharmaceutical industry for rapid N-glycosylation profiling of therapeutic antibodies. , To meet ...
(Date:3/22/2017)... ... March 21, 2017 , ... ... innovative Quantum peristaltic pump with patented ReNu single-use (SU) cartridge technology. Engineered ... for high-pressure feed pumps in SU tangential flow filtration (TFF), virus filtration ...
(Date:3/22/2017)... and PETACH TIKVAH, Israel , March ... a leading developer of adult stem cell technologies for ... Chief Executive Officer, will provide an update on new ... nd Annual Neuroscience Biopartnering and Investment Forum, being ... York Academy of Sciences. ...
Breaking Biology Technology:
(Date:2/22/2017)... Feb. 22, 2017 With the biometrics ... Research identifies four technologies that innovative and agile ... significant share in the changing competitive landscape: multifactor ... authentication.   "Companies can no longer ... security," says Dimitrios Pavlakis , Industry Analyst ...
(Date:2/21/2017)... 21, 2017 Der weltweite Biobanking-Sektor ... Nach einem Gespräch mit mehr als 50 Vertretern aus verschiedenen ... überwinden gilt, um diese Prognose zu realisieren. ... Zu ... der finanziellen Mittel für die Biobank, die Implementierung Zeit ...
(Date:2/14/2017)...  Wake Forest Baptist Medical Center today announced Julie Ann ... officer (CEO). Freischlag joins the medical center on May ... M.D., who last year announced that he would transition ... leading it since 2008.   As CEO, ... Baptist,s academic health system, which includes Wake Forest School ...
Breaking Biology News(10 mins):